Table 4.
Temporal trend for DR screening by MBS item across age groups per 100,000 people with diabetes*
| 2016 to 2017 | 2017 to 2018 | 2018 to 2019 | 2019 to 2020 | 2020 to 2021 | 2021 to 2022 | 2022 to 2023 | 2023 to 2024 | |
|---|---|---|---|---|---|---|---|---|
| < 25 years | ||||||||
| MBS 12,326 | 40 | 220 | 459 | 499 | 180 | 279 | 439 | 339 |
| MBS 12,325 | 120 | 459 | 659 | 579 | 758 | 279 | 299 | 379 |
| Total | 160 | 679 | 1118 | 1078 | 938 | 558 | 738 | 718 |
| 25–44 years | ||||||||
| MBS 12,326 | 16 | 46 | 84 | 182 | 137 | 119 | 116 | 52 |
| MBS 12,325 | 42 | 140 | 183 | 133 | 149 | 82 | 90 | 99 |
| Total | 58 | 186 | 267 | 315 | 286 | 201 | 206 | 151 |
| 45–64 years | ||||||||
| MBS 12,326 | 23 | 56 | 85 | 151 | 102 | 81 | 97 | 44 |
| MBS 12,325 | 33 | 93 | 158 | 122 | 117 | 69 | 69 | 89 |
| Total | 56 | 149 | 243 | 273 | 219 | 150 | 166 | 133 |
| 65–74 years | ||||||||
| MBS 12,326 | 21 | 67 | 67 | 139 | 96 | 74 | 99 | 50 |
| MBS 12,325 | 12 | 53 | 64 | 51 | 60 | 40 | 37 | 40 |
| Total | 33 | 120 | 131 | 190 | 156 | 114 | 136 | 90 |
| ≥ 75 years | ||||||||
| MBS 12,326 | 18 | 39 | 40 | 73 | 41 | 33 | 54 | 26 |
| MBS 12,325 | 3 | 21 | 21 | 19 | 17 | 14 | 10 | 11 |
| Total | 21 | 60 | 61 | 92 | 58 | 47 | 64 | 37 |
*Three states (TAS, NT & ACT) were excluded as age-group-wise diabetes prevalence data were not available for those states